NGL Fine Chem Limited has announced the resignation of Mrs. Pallavi Pednekar from her position as Company Secretary and Compliance Officer, effective from the close of business hours on January 23, 2026. The pharmaceutical company informed both BSE Limited and National Stock Exchange of India Limited about this key managerial personnel change in compliance with regulatory requirements.

Resignation Details and Timeline

Mrs. Pallavi Pednekar submitted her resignation letter on January 5, 2026, expressing her intention to pursue career opportunities outside the organization. The resignation follows proper regulatory protocols under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance and Documentation

The company has fulfilled all mandatory disclosure requirements by providing comprehensive details to stock exchanges. Mrs. Pednekar confirmed in her resignation letter that there are no material reasons for her departure other than pursuing external career interests. The resignation letter was addressed to the Board of Directors and included proper acknowledgment of regulatory compliance requirements.

NGL Fine-Chem Limited's Managing Director Rahul Nachane (DIN: 00223346) signed the official intimation to stock exchanges, ensuring proper corporate governance protocols were followed throughout the process.

Succession Planning

The company has indicated that it is actively engaged in identifying and hiring a suitable candidate to fill the vacant position. NGL Fine-Chem Limited has committed to informing stock exchanges once the replacement process is completed, ensuring continuity in compliance and secretarial functions.

Corporate Acknowledgment

In her resignation letter, Mrs. Pednekar expressed gratitude to the Board of Directors, senior management, and colleagues for their support, guidance, and cooperation during her tenure. She specifically requested the company to arrange proper submission of required intimations to stock exchanges and filing of necessary forms with the Registrar of Companies, Mumbai, demonstrating her commitment to ensuring smooth transition procedures.

NGL Fine Chem Limited, a prominent player in the fine chemicals sector, has released its financial results for the second quarter of the fiscal year 2025-2026, showcasing a mixed performance with significant revenue growth but a marginal decline in profits.

Financial Highlights

Revenue Growth

NGL Fine Chem reported a substantial increase in its consolidated revenue, which rose to ₹1,200.00 crore in Q2 FY2026, up from ₹935.00 crore in the same period last year. This represents a robust year-over-year growth of 28.34%, indicating strong demand for the company's products and potentially expanded market reach.

Profit Performance

Despite the impressive revenue growth, the company's net profit saw a slight decrease. NGL Fine Chem posted a consolidated net profit of ₹96.00 crore for the quarter, compared to ₹98.00 crore in the corresponding quarter of the previous fiscal year, marking a marginal decline of 2.04%.

EBITDA and Margins

The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) showed significant improvement, rising to ₹171.00 crore from ₹116.00 crore in the year-ago period, representing a 47.41% increase. However, the EBITDA margin contracted to 14.25% from 17.28% in the previous year, a decrease of 303 basis points.

Management Approval

According to the LODR (Listing Obligations and Disclosure Requirements) data, the Board of Directors of NGL Fine Chem Limited approved these unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025, in their meeting held on November 12, 2025.

The mixed results present a nuanced picture of NGL Fine Chem's performance. While the substantial revenue growth is a positive indicator, the slight dip in profits and the decrease in EBITDA margin may warrant attention from investors and analysts. The company's ability to manage costs and improve profitability while maintaining its growth trajectory will be crucial factors to watch in the coming quarters.